A method of inhibiting pro-inflammatory mediator release from basophils or mast cells to treat an inflammatory disease in a mammal, comprising administering to the mammal a therapeutically effective amount of one or more of the following proteins, MIP-1.alpha., MIP-1.beta., CTAP-III, or IP-10....http://www.google.com/patents/US5474983?utm_source=gb-gplus-sharePatent US5474983 - Method of inhibiting pro-inflammatory mediator release from basophils and mast cells
